 | Up a level |
Baty, Florent; Rothschild, Sacha; Früh, Martin; Betticher, Daniel; Dröge, Cornelia; Cathomas, Richard; Rauch, Daniel; Gautschi, Oliver; Bubendorf, Lukas; Crowe, Susanne; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Swiss Group for Clinical Cancer Research, on behalf of the (2013). EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer. PLoS ONE, 8(9), e72966. Public Library of Science 10.1371/journal.pone.0072966
Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendorf, Lukas; Ochsenbein, Adrian; Gautschi, Oliver; Oppliger Leibundgut, Elisabeth; Froesch, Patrizia; Stahel, Rolf; Hess, Thomas; Rauch, Daniel; Schmid, Petra; Mayer, Michael; Crowe, Susanne; Brauchli, Peter; Ribi, Karin; Pless, Miklos; on behalf of the Swiss Group for Clinical Cancer Research (SAKK), (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05). Lung cancer, 78(3), pp. 239-44. Amsterdam: Elsevier 10.1016/S1359-6349(09)71860-9
Geretschläger, Andreas; Bojaxhiu, Beat; Crowe, Susanne; Arnold, Andreas; Manser, Peter; Hallermann, Wock; Aebersold, Daniel M.; Ghadjar, Pirus (2012). Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma. Radiation oncology, 7, p. 175. London: BioMed Central 10.1186/1748-717X-7-175
Cihoric, Nikola; Crowe, Susanne; Eychmüller, Steffen; Aebersold, Daniel M.; Ghadjar, Pirus (2012). Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiation oncology, 7, p. 132. London: BioMed Central 10.1186/1748-717X-7-132
